menu
    • menu

    Company profile for Quell Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, ...
    At Quell we seek to deliver truly innovative, life-changing therapies for our patients. Our vision as a company is to build a major global biopharmaceutical company bringing transformational and valued therapies for a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation, based on modular engineered Tregs.Quell is focused on delivering therapies which are valued by physicians, patients and payors, which have the promise of delivering transformational results for our patients.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Quell Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Translation & Innovation Hub 84 Wood Lane London
    Telephone
    Telephone
    0207 096 9012
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://quell-tx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/quell-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Product Expo West

    Natural Product Expo West

    Not Confirmed

    envelop Contact Supplier

    Natural Product Expo West

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Quell Halts Transplant Trial To Focus On 'Chill Not Kill' Treg
    Quell Halts Transplant Trial To Focus On 'Chill Not Kill' Treg

    05 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/quell-halts-liver-transplant-treg-trial-focus-preclinical-chill-not-kill-candidate

    FIERCE BIOTECH
    05 Feb 2026
    Share Share
    Quell Therapeutics To Present Positive QEL-005, CAR-Treg Data
    Quell Therapeutics To Present Positive QEL-005, CAR-Treg Data

    25 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/25/3174167/0/en/Quell-Therapeutics-to-Unveil-Promising-Data-for-QEL-005-a-Novel-CAR-Treg-Cell-Therapy-for-Complex-Autoimmune-Diseases-at-ACR-Convergence-2025.html

    GLOBENEWSWIRE
    25 Oct 2025
    Share Share
    Quell Therapeutics Forms Elite Scientific Advisory Board
    Quell Therapeutics Forms Elite Scientific Advisory Board

    27 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/27/3139858/0/en/Quell-Therapeutics-Establishes-World-Class-Scientific-Advisory-Board.html

    GLOBENEWSWIRE
    27 Aug 2025
    Share Share
    Quell Therapeutics Hits Milestone in CAR-Treg for IBD
    Quell Therapeutics Hits Milestone in CAR-Treg for IBD

    10 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/10/3096491/0/en/Quell-Therapeutics-Achieves-Key-Milestone-in-its-CAR-Treg-Cell-Therapy-Program-for-Inflammatory-Bowel-Disease.html

    GLOBENEWSWIRE
    10 Jun 2025
    Share Share
    AGC Biologics Partners with Quell for Cell Therapy Development
    AGC Biologics Partners with Quell for Cell Therapy Development

    17 May 2025

    // PRESS RELEASE

    https://www.agcbio.com/news/agc-biologics-partners-with-quell-therapeutics-cell-therapy-cdmo-alliance-ind-submission-preparedness

    PRESS RELEASE
    17 May 2025
    Share Share
    Quell Achieves Milestone for T1D CAR-Treg Cell Therapy Program
    Quell Achieves Milestone for T1D CAR-Treg Cell Therapy Program

    18 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/18/2982494/0/en/Quell-Therapeutics-Achieves-Milestone-for-Type-1-Diabetes-CAR-Treg-Cell-Therapy-Program.html

    GLOBENEWSWIRE
    18 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search